1-(4-Methyl-2-methylthio-pyrimidin-5-yl)-ethanone, 98.0%, 100mg

4-Bromo-2-ethoxy-6-fluorobenzaldehyde, 250mg

tert-Butyl (3aR,5S,7aR)-5-(hydroxymethyl)hexahydropyrano[3,2-b]pyrrole-1(2H)-carboxylate, 95%, 100mg

Ethenesulfonamide, 97%, 100mg

((4S)-2,2-Dimethyl-5-oxo-1,3-dioxolan-4-yl)acetic, 95.0%, 25g

2',3'-Di-O-acetyl-5'-deoxy-5-fluorocytidine>98.0%(HPLC)(T)5g

2-(trifluoromethoxy)-L-phenylalanine hydrochloride, 250mg

4,4'-(Cyclopent-1-ene-1,2-diyl)bis(5-methylthiophene-2-carbaldehydE), 97%, 250mg

5-bromo-4-methoxy-1H-1,3-benzodiazole, 97%, 250mg

tert-Butyl 4-bromo-2-oxo-1,2-dihydrospiro[indole-3,4'-piperidine]-1'-carboxylate, 50mg

3,4-Dichlorobenzaldehyde, 97.0%, 1g

5-TAMRA-PEG3 azida, mínimo 90 %, 100 mg, envase de plástico.

(S)-(-)-3-Amino-2-piperidone>98.0%(GC)5g